Zim Laboratories reported a Q1 FY27 net loss of ₹4 crore, widening from ₹1.9 crore a year ago. However, revenue grew 31.2% to ₹94.2 crore, driven by exports. Strategic investments and non-recurring costs impacted profitability.
Zim Laboratories Reports Q1 FY27 Results
Revenue Growth: 31.2% YoY
Reported PAT: Loss of ₹4.0 crore
Reader Takeaway: Healthy revenue momentum despite a widened net loss due to strategic investments and compliance costs.